MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus | Vaccines

MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus

Related Keywords

Shanghai ,China ,Denmark ,Hong Kong ,Copenhagen ,Køavn ,Wellington ,New Zealand General ,New Zealand ,Uganda ,United Kingdom ,South Africa ,San Francisco ,California ,United States ,New York ,London ,City Of ,Mumbai ,Maharashtra ,India ,Danish ,Vincent Brichard ,Youtube ,Groupb Streptococcus ,Groupb Strep International ,Lund University ,Maternal Vaccine Against Groupb Streptococcus ,Instagram ,Twitter ,Novo Holdings ,Groupb Strep ,Linkedin ,Upsized Financing To Advance The Development ,Life Sciences ,Minervax Raises ,Upsized Financing ,Maternal Vaccine ,Denmarki October ,Minervax Aps ,Pureos Ventures ,Sanofi Ventures ,Trill Impact Ventures ,Adjuvant Capital ,Wellington Partners ,Sunstone Lifescience Ventures ,Tal Zaks ,Minervax Board ,Older Adults ,Venture Partner ,Groupb Strep Support ,New York City ,Vaccine ,Immunotherapy ,Immune Therapy ,Desensitization ,Personalized Immunotherapy ,Ntigen ,Ellular ,Recombinant ,Protein ,Peptide ,Subunit ,Multivalent ,Cancer Vaccine ,